Union Quimico Farmaceutica Sa (uquifa), based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RANOLAZINE, with a corresponding US DMF Number 31940.
Remarkably, this DMF maintains an Active status since its submission on August 01, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2017, and payment made on August 07, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II